UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial. - Wikidata - awgldk - TriplyDB

UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial.

UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial.

http://www.wikidata.org/entity/Q35550020

about

Impact of UVA exposure on psychological parameters and circulating serotonin and melatonin.UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review Photosensitivity in cutaneous lupus erythematosus SF-36 total score as a single measure of health-related quality of life: Scoping review Porcine skin as a model system for studies of adverse effects of narrow-band UVB pulses on human skin.Interstitial lung disease and pulmonary hypertension responsive to low-dose ultraviolet A1 irradiation in lupus.Optimal management of fatigue in patients with systemic lupus erythematosus: a systematic review.Ultraviolet-A1 phototherapy modulates Th1/Th2 and Tc1/Tc2 balance in patients with systemic lupus erythematosus.Ultraviolet A1 phototherapy.Phototherapy, photodynamic therapy and photophoresis in the treatment of connective-tissue diseases: a review.UVA-1 Phototherapy.A review of health related quality of life in systemic lupus erythematosus.Ultraviolet-A1 irradiation therapy for systemic lupus erythematosus.Chronic graft-versus-host-disease-like dermopathy in a child with CD4+ cell microchimerism.Reversal of brain dysfunction with UV-A1 irradiation in a patient with systemic lupus.

P2860

Q24793251-86B585FE-11CA-4D76-9BE0-44CAE28D98BC Q24798336-991F48FF-E11A-4D37-B8F5-565DAC374232 Q26863253-175FECFE-71AF-4B3C-A96F-2ABB5C0814C3 Q28066146-99D40DCA-4351-4F68-B91A-4276206C185B Q33474954-92436E10-1FC7-4A62-9DEC-AB26451936B3 Q33951047-FE61ABE8-DC75-4358-95D4-588BDD531223 Q34351248-B24D59FA-35A9-4294-8174-0E33D81BD896 Q34411021-C631DB42-59DE-4BD2-8433-033733EAF559 Q35129439-E7D20D89-13A9-4358-8967-A0E26703839A Q35423702-D3D81DDA-6438-4F47-A378-FA9CD6E1B210 Q36063936-26BE4653-974D-4D1E-B0D2-86B5B1B4981C Q36660670-DB042D9A-41F3-4AC1-BA28-13AEDD84D1B0 Q41371611-FF4FDE69-2DC5-4B5E-ABF8-9F124E463CAD Q45190467-E63D763C-4F76-47CF-B73B-552217B6A329 Q48249217-1CC58358-D8AA-4BD4-8461-8CB548207D15

P2860

UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial.

http://www.wikidata.org/entity/Q35550020

description

2001 nî lūn-bûn

@nan

2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial.

@ast

UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial.

@en

type

label

UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial.

@ast

UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial.

@en

prefLabel

UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial.

@ast

UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial.

@en

P1433

Q35550020-FED7D049-E8EE-4DAC-974A-ED8806398043

P1476

Q35550020-66334CD0-5BFB-43ED-9482-32DC536FB542

P2093

Q35550020-1526DA8C-B3FC-48E8-B942-21202D6506CF

Q35550020-A63AE4AA-C663-4C3F-9308-07CE39F7435B

Q35550020-E05A4159-41AB-4AA1-B522-83834CF85946

Q35550020-E8CF6E01-E3D3-4465-9275-C17FBE8C562D

P2860

Q35550020-379EA3D8-15D7-4CF1-9245-D771E504FDA0

Q35550020-3B144C8F-F693-49E2-8D2D-A7FC0D99023E

Q35550020-43DA1D8C-73D5-4F80-BDE2-8405CEE66CCE

Q35550020-8EFF8F44-B588-4E3A-A9F3-90E6245D34C8

Q35550020-9162DAE9-319A-4CA5-89E5-1653E3C783A8

Q35550020-B161B367-67EC-46CE-A3B3-322D501CFB1A

Q35550020-BA99681E-85B1-4BD6-A240-3F1B258A84F4

Q35550020-D11574C5-DB9F-43D1-81D4-5E007A705AF7

P304

Q35550020-31237A16-E285-4CB3-A458-3696F43DB3B6

P31

Q35550020-B9AEBDA5-1F94-4211-B5C8-BD387137E546

P356

Q35550020-D61C5834-BEE4-4172-82B3-45196C1E7D7D

P407

Q35550020-C7D6B0EC-E1A3-40E8-8A1C-4213D9CC0A37

P433

Q35550020-F872318E-ACC3-40A6-9CBC-2D2CD20820F6

P478

Q35550020-1E9B826E-1243-4914-AF21-71CC3B1C734C

P577

Q35550020-FB031AD7-DEE9-40B3-895D-6BB964F957BF

P5875

Q35550020-D52BF830-BD70-46F8-855B-5AC29E047EE7

P698

Q35550020-421E411A-B37B-4694-9CB5-6A62D4961DC7

P921

Q35550020-18B0FBB5-5B09-4222-AD32-D2DCA3D11D39

P932

Q35550020-E23AA4B0-349A-4924-A0D5-20C74E1A5E66

P356

P1433

Annals of the Rheumatic Diseases

P1476

UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial.

@en

P2093

Huizinga TW

http://www.w3.org/2001/XMLSchema#string

Le Cessie S

http://www.w3.org/2001/XMLSchema#string

Pavel S

http://www.w3.org/2001/XMLSchema#string

Polderman MC

http://www.w3.org/2001/XMLSchema#string

P2860

The MOS 36-ltem Short-Form Health Survey (SF-36)

Ultraviolet-A light prolongs survival and improves immune function in (New Zealand black x New Zealand white)F1 hybrid mice.

Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice.

Prospects for UV-A1 therapy as a treatment modality in cutaneous and systemic LE.

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

[UV-A-1 therapy of subacute cutaneous lupus erythematosus]

High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial.

P304

112-115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.60.2.112

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2001-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274443748

http://www.w3.org/2001/XMLSchema#string

P698

11156542

http://www.w3.org/2001/XMLSchema#string

P921

P932

1753460

http://www.w3.org/2001/XMLSchema#string